Astrazeneca Pharma India Ltd

Astrazeneca Pharma India is engaged in the business of manufacture, distribution and marketing of pharmaceutical products.(Source : 201903 Annual Report Page No: 72)

Pros:
Company is virtually debt free.
Company is expected to give good quarter
Company has good consistent profit growth of 39.13% over 5 years
Cons:
Stock is trading at 18.94 times its book value
Though the company is reporting repeated profits, it is not paying out dividend
The company has delivered a poor growth of 8.98% over past five years.
Company has a low return on equity of 13.76% for last 3 years.

Peer Comparison Sector: Pharmaceuticals // Industry: Pharmaceuticals - Multinational

Loading peers table ...

Quarterly Results Figures in Rs. Crores

Sep 2016 Dec 2016 Mar 2017 Jun 2017 Sep 2017 Dec 2017 Mar 2018 Jun 2018 Sep 2018 Dec 2018 Mar 2019 Jun 2019
138 150 116 127 164 129 151 161 161 215 190 205
135 135 115 121 129 139 135 152 147 174 184 169
Operating Profit 3 15 1 6 36 -11 15 9 15 41 6 36
OPM % 2% 10% 1% 5% 22% -8% 10% 6% 9% 19% 3% 17%
Other Income 2 10 1 5 2 3 2 3 3 4 6 3
Interest 0 0 0 0 0 0 0 0 0 0 0 0
Depreciation 4 4 4 4 4 4 4 4 4 4 4 5
Profit before tax 1 21 -2 7 34 -12 14 9 14 41 8 34
Tax % 19% 23% -380% 19% 20% 12% 77% 30% 37% 28% -16% 36%
Net Profit 1 16 -10 6 27 -10 3 6 9 29 10 22
EPS in Rs 0.32 6.48 -3.82 2.32 10.95 -4.14 1.29 2.58 3.65 11.64 3.93 8.61
Notes Notes Notes Notes Notes Notes Notes Notes Notes Notes Notes Notes

Profit & Loss Figures in Rs. Crores

Dec 2007 Dec 2008 Dec 2009 Mar 2011 Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 TTM
302 353 397 594 531 390 474 517 564 544 571 728 771
211 241 307 490 501 459 487 528 547 507 525 657 674
Operating Profit 92 113 90 104 30 -68 -13 -11 16 37 46 71 98
OPM % 30% 32% 23% 17% 6% -18% -3% -2% 3% 7% 8% 10% 13%
Other Income 10 14 5 6 6 10 23 6 7 14 12 16 16
Interest 0 5 0 0 0 0 0 0 0 0 0 0 0
Depreciation 6 7 6 9 7 12 10 15 17 16 15 15 16
Profit before tax 95 114 88 101 29 -70 0 -21 6 36 44 73 97
Tax % 36% 35% 35% 36% 32% -27% -0% 9% 44% 41% 25%
Net Profit 61 74 58 64 20 -90 -1 -21 5 20 26 54 70
EPS in Rs 22.04 26.99 21.35 19.25 7.34 0.00 0.00 0.00 2.10 8.02 10.36 21.78 27.83
Dividend Payout % 61% 51% 43% 39% 44% -0% -0% -0% 0% 0% 0% 0%
* Sales is net of excise duty and discounts
Compounded Sales Growth
10 Years:7.50%
5 Years:8.98%
3 Years:8.91%
TTM:27.51%
Compounded Profit Growth
10 Years:-3.03%
5 Years:39.13%
3 Years:118.44%
TTM:161.11%
Stock Price CAGR
10 Years:10.18%
5 Years:22.67%
3 Years:33.01%
1 Year:34.91%
Return on Equity
10 Years:6.25%
5 Years:7.94%
3 Years:13.76%
Last Year:19.87%

Balance Sheet Figures in Rs. Crores

Dec 2007 Dec 2008 Dec 2009 Mar 2011 Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019
5 5 5 5 5 5 5 5 5 5 5 5
Reserves 154 111 140 175 184 95 167 146 151 218 242 296
Borrowings 0 62 0 0 0 0 0 0 0 0 0 0
90 112 91 131 157 206 244 261 247 196 215 262
Total Liabilities 249 291 236 310 346 306 416 412 403 419 462 563
33 30 30 27 32 25 94 101 97 87 75 75
CWIP 0 0 0 24 58 74 9 12 6 5 4 7
Investments 0 0 0 0 0 0 0 0 0 0 0 0
216 260 206 259 256 208 312 298 299 327 383 481
Total Assets 249 291 236 310 346 306 416 412 403 419 462 563

Cash Flows Figures in Rs. Crores

Dec 2007 Dec 2008 Dec 2009 Mar 2011 Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019
40 82 33 64 39 -6 -1 -46 57 38 9 55
-3 5 2 -28 -34 -16 -15 -19 -4 0 -9 4
-34 -54 -111 -29 -29 -10 86 0 -1 0 0 0
Net Cash Flow 3 33 -76 8 -24 -32 71 -64 53 38 -1 59

Ratios Figures in Rs. Crores

Dec 2007 Dec 2008 Dec 2009 Mar 2011 Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019
ROCE % 63% 71% 55% 62% 15% -53% -12% -13% 4% 15% 19% 27%
Debtor Days 57 52 63 27 22 26 41 30 54 29 35 40
Inventory Turnover 10.47 12.23 11.46 12.86 8.03 4.86 5.23 5.69 6.92 8.09 6.68 6.30